Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Long-term proton pump inhibitor therapy and risk of hip fracture.

Yang YX, Lewis JD, Epstein S, Metz DC.

JAMA. 2006 Dec 27;296(24):2947-53.

PMID:
17190895
2.

Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies.

Ngamruengphong S, Leontiadis GI, Radhi S, Dentino A, Nugent K.

Am J Gastroenterol. 2011 Jul;106(7):1209-18; quiz 1219. doi: 10.1038/ajg.2011.113. Epub 2011 Apr 12. Review.

PMID:
21483462
3.

Proton pump inhibitors and bone fractures?

Laine L.

Am J Gastroenterol. 2009 Mar;104 Suppl 2:S21-6. doi: 10.1038/ajg.2009.48. Review.

PMID:
19262543
4.

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.

Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D.

Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. Review.

5.

Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.

Sigterman KE, van Pinxteren B, Bonis PA, Lau J, Numans ME.

Cochrane Database Syst Rev. 2013 May 31;(5):CD002095. doi: 10.1002/14651858.CD002095.pub5. Review.

PMID:
23728637
6.

Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.

van Pinxteren B, Sigterman KE, Bonis P, Lau J, Numans ME.

Cochrane Database Syst Rev. 2010 Nov 10;(11):CD002095. doi: 10.1002/14651858.CD002095.pub4. Review. Update in: Cochrane Database Syst Rev. 2013;5:CD002095.

PMID:
21069670
7.

Acid suppression therapy: where do we go from here?

Scarpignato C, Pelosini I, Di Mario F.

Dig Dis. 2006;24(1-2):11-46. Review.

PMID:
16699262
8.

[Proton pump inhibitors (PPI): may be not as harmless as believed].

Reinberg O.

Rev Med Suisse. 2015 Sep 9;11(485):1665-71. Review. French.

PMID:
26540997
9.

Management strategies for gastroesophageal reflux disease.

Bak YT.

J Gastroenterol Hepatol. 2004 Sep;19 Suppl 3:S49-53. Review.

PMID:
15324382
10.

The effect of proton pump-inhibiting drugs on mineral metabolism.

Insogna KL.

Am J Gastroenterol. 2009 Mar;104 Suppl 2:S2-4. doi: 10.1038/ajg.2009.44. Review.

PMID:
19262542
15.

Proton pump inhibitors therapy and risk of hip fracture: a systematic review and meta-analysis.

Ye X, Liu H, Wu C, Qin Y, Zang J, Gao Q, Zhang X, He J.

Eur J Gastroenterol Hepatol. 2011 Sep;23(9):794-800. doi: 10.1097/MEG.0b013e328348a56a. Review.

PMID:
21701389
16.

Potential adverse effects of proton pump inhibitors.

Coté GA, Howden CW.

Curr Gastroenterol Rep. 2008 Jun;10(3):208-14. Review.

PMID:
18625128
17.

Proton pump-inhibiting drugs, calcium homeostasis, and bone health.

Wright MJ, Proctor DD, Insogna KL, Kerstetter JE.

Nutr Rev. 2008 Feb;66(2):103-8. doi: 10.1111/j.1753-4887.2008.00015.x. Review.

PMID:
18254877
18.

Fracture risk and bone mineral density reduction associated with proton pump inhibitors.

Lau YT, Ahmed NN.

Pharmacotherapy. 2012 Jan;32(1):67-79. doi: 10.1002/PHAR.1007. Review.

PMID:
22392829
19.

The relationship between long-term proton pump inhibitor therapy and skeletal frailty.

Lau AN, Tomizza M, Wong-Pack M, Papaioannou A, Adachi JD.

Endocrine. 2015 Aug;49(3):606-10. doi: 10.1007/s12020-015-0576-z. Epub 2015 May 7. Review.

20.

Nutritional consequences of long-term acid suppression; are they clinically important?

Johnson DA.

Curr Opin Gastroenterol. 2016 Mar;32(2):136-40. doi: 10.1097/MOG.0000000000000250. Review.

PMID:
26760397

Supplemental Content

Support Center